3rd Quarter - Report — BROWNSTEIN HYATT FARBER SCHRECK, LLP for AIPHARMA GLOBAL HOLDINGS LIMITED (2021)

Firm

BROWNSTEIN HYATT FARBER SCHRECK, LLP

Client

AIPHARMA GLOBAL HOLDINGS LIMITED

Income

$80,000

Expenses

—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to the pharmaceutical supply chain

Lobbyist	Covered position, as disclosed
LAURA JOHNSON BOLLIER	—
DAVID PHILLIP COHEN	—
ANDREW LITTMAN	—
MARK L. PRYOR	—
ADAM STEINMETZ	—

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); Health & Human Services, Dept of (HHS); White House Office

Pharmacy PHA

Issues related to the pharmaceutical supply chain

Lobbyist	Covered position, as disclosed
EMILY FELDER	—

Contacted: White House Office; Natl Institutes of Health (NIH); Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.